Results 91 to 100 of about 56,712 (295)

Living With Chronic Rhinosinusitis: Insights From an Arts‐Based Study

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Background Chronic rhinosinusitis (CRS) significantly reduces quality of life (QoL), but data regarding the extent of its impact is sparse. Questionnaire‐based assessments of QoL may neglect aspects of complex patient experiences. Recent studies on asthma patients and other chronic conditions have used self‐expression through artwork to better
Jenny Xiao   +4 more
wiley   +1 more source

Obesity and gastroesophageal reflux disease and gastroesophageal reflux symptoms in children

open access: yesClinical and Experimental Gastroenterology, 2009
Hoda M Malaty1, J Kennard Fraley1,2, Suhaib Abudayyeh1, Kenneth W Fairly1, Ussama S Javed1, et al1Department of Medicine, 2Children’s Nutrition Research Center (CNRC), 4Department of Pediatrics, 5Texas Children’s Hospital, Baylor ...
Hoda M Malaty, J Kennard Fraley   +4 more
doaj  

Causal Relationships Between Gastroesophageal Reflux Disease and Myocardial Infarction: Insights From Univariable and Multivariable Mendelian Randomization Analyses

open access: yesAnnals of Human Genetics, EarlyView.
ABSTRACT Background Observational studies have indicated that gastroesophageal reflux disease (GERD) is connected to myocardial infarction (MI). Nonetheless, the question of causality in these relationships remains unresolved, given the potential influence of confounding variables.
Xiaoya Zheng   +5 more
wiley   +1 more source

Gastroesophageal Reflux Disease (GERD) and Outcome at One Year of Age in Very Low Birth-Weight (VLBW) Infants, with and without Chronic Lung Disease (CLD) 1254 [PDF]

open access: bronze, 1998
Mamta Fuloria   +5 more
openalex   +1 more source

Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis

open access: yesAllergy, EarlyView.
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller   +13 more
wiley   +1 more source

Round table discussion on gastroesophageal reflux disease

open access: bronze, 1978
Rekha Goyal   +4 more
openalex   +1 more source

Gastrointestinal Barrier Disruption in Post‐COVID Syndrome Fatigue Patients

open access: yesAllergy, EarlyView.
Gastrointestinal (GI) barrier disruption in the context of SARS‐CoV‐2 infection is associated with the development of Post‐COVID Syndrome (PCS) Fatigue. Pre‐existing GI complaints may predispose to fatigue development. Monitoring GI symptoms and markers before, during, and after SARS‐CoV‐2 infection is crucial for identifying predictive clinical ...
Johanna Rohrhofer   +8 more
wiley   +1 more source

Oral alterations associated to gastroesophageal reflux disease

open access: yesRevista Cubana de Estomatología, 2020
Introduction: Gastroesophageal reflux disease is a functional multifactorial disorder of the upper gastrointestinal tract. Oral alterations are considered to be extraesophageal manifestations of this disease.
Yulisa Otero Baxter   +3 more
doaj  

Pathophysiology of Gastroesophageal Reflux and Distal Esophageal Motility in Children with Gastroesophageal Reflux Disease

open access: bronze, 1988
Salvatore Cucchiara   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy